Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway

被引:333
作者
Cao, Weiping [1 ]
Manicassamy, Santhakumar [1 ]
Tang, Hua [1 ]
Kasturi, Sudhir Pai [1 ]
Pirani, Ali [2 ]
Murthy, Niren [3 ]
Pulendran, Bali [1 ,4 ]
机构
[1] Emory Vaccine Ctr, Atlanta, GA 30329 USA
[2] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[3] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA
[4] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ni.1645
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Robust production of type I interferon (IFN-alpha/beta) in plasmacytoid dendritic cells (pDCs) is crucial for antiviral immunity. Here we show involvement of the mammalian target of rapamycin ( mTOR) pathway in regulating interferon production by pDCs. Inhibition of mTOR or its 'downstream' mediators, the p70 ribosomal S6 protein kinases p70S6K1 and p70S6K2, during pDC activation by Toll-like receptor 9 (TLR9) blocked the interaction of TLR9 with the adaptor MyD88 and subsequent activation of the interferon-regulatory factor IRF7, which resulted in impaired IFN-alpha/beta production. Microarray analysis confirmed that inhibition of mTOR by the immunosuppressive drug rapamycin suppressed antiviral and anti-inflammatory gene expression. Consistent with this, targeting rapamycin-encapsulated microparticles to antigen-presenting cells in vivo resulted in less IFN-alpha/beta production in response to CpG DNA or the yellow fever vaccine virus strain 17D. Thus, mTOR signaling is crucial in TLR-mediated IFN-alpha/beta responses by pDCs.
引用
收藏
页码:1157 / 1164
页数:8
相关论文
共 40 条
[1]   Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology [J].
Asselin-Paturel, C ;
Boonstra, A ;
Dalod, M ;
Durand, I ;
Yessaad, N ;
Dezutter-Dambuyant, C ;
Vicari, A ;
O'Garra, A ;
Biron, C ;
Brière, F ;
Trinchieri, G .
NATURE IMMUNOLOGY, 2001, 2 (12) :1144-1150
[2]   Type I interferon in systemic lupus erythematosus and other autoimmune diseases [J].
Banchereau, Jacques ;
Pascual, Virginia .
IMMUNITY, 2006, 25 (03) :383-392
[3]   Translational control of the innate immune response through IRF-7 [J].
Colina, Rodney ;
Costa-Mattioli, Mauro ;
Dowling, Ryan J. O. ;
Jaramillo, Maritza ;
Tai, Lee-Hwa ;
Breitbach, Caroline J. ;
Martineau, Yvan ;
Larsson, Ola ;
Rong, Liwei ;
Svitkin, Yuri V. ;
Makrigiannis, Andrew P. ;
Bell, John C. ;
Sonenberg, Nahum .
NATURE, 2008, 452 (7185) :323-U2
[4]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226
[5]   mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer [J].
Dann, Stephen G. ;
Selvaraj, Anand ;
Thomas, George .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (06) :252-259
[6]   Danger signals: SOS to the immune system [J].
Gallucci, S ;
Matzinger, P .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (01) :114-119
[7]   PI3K is critical for the nuclear translocation of IRF-7 and type IIFN production by human plasmacytoid predendritic cells in response to TLR activation [J].
Guiducci, Cristiana ;
Ghirelli, Cristina ;
Marloie-Provost, Marie-Annick ;
Matray, Tracy ;
Coffman, Robert L. ;
Liu, Yong-Jun ;
Barrat, Franck J. ;
Soumelis, Vassili .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (02) :315-322
[8]   Upstream and downstream of mTOR [J].
Hay, N ;
Sonenberg, N .
GENES & DEVELOPMENT, 2004, 18 (16) :1926-1945
[9]   Role of phosphoinositide 3-kinase in innate immunity [J].
Hazeki, Kaoru ;
Nigorikawa, Kiyomi ;
Hazeki, Osamu .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (09) :1617-1623
[10]   Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction [J].
Honda, K ;
Ohba, Y ;
Yanai, H ;
Negishi, H ;
Mizutani, T ;
Takaoka, A ;
Taya, C ;
Taniguchi, T .
NATURE, 2005, 434 (7036) :1035-1040